ArticleCells2026

The ApoA-IV-LRP1 Signaling Axis: A Novel Insulin-Independent Pathway for the Suppression of Diabetic Hyperglucagonemia.

Min Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.